38.54
5.69%
1.9684
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
AnaptysBio chief legal officer sells over $490k in company stock By Investing.com - Investing.com South Africa
AnaptysBio chief legal officer sells over $490k in company stock - Investing.com
A Guide To The Risks Of Investing In AnaptysBio Inc (ANAB) - Knox Daily
TD Asset Management Inc Raises Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
Bioventus Inc [BVS] stock for 683,736 USD was bought by Bartholdson John A. - Knox Daily
Insider Selling: Lizzul Paul F., AnaptysBio Inc [ANAB] Chief Medical Officer divested 2,000 shares - Knox Daily
BTIG Reiterates Buy Rating on Anaptysbio (ANAB) (correction) - StreetInsider.com
AnaptysBio (NASDAQ:ANAB) Shares Down 3.2% - MarketBeat
Analysts Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $50.30 - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Learn to Evaluate (ANAB) using the Charts - Stock Traders Daily
Anaptys Announces Participation in September Investor Conferences - ForexTV.com
Anaptys Announces Participation in September Investor Conferences - Yahoo Finance UK
Anaptys Announces Participation in September Investor Conferences - StockTitan
Why AnaptysBio Was Such a Healthy Stock This Week - sharewise
Why AnaptysBio Was Such a Healthy Stock This Week - Yahoo Finance
Alopecia Areata Clinical Trials 2024: FDA Approvals, Pipeline, - openPR
Contrasting AstraZeneca (NASDAQ:AZN) & AnaptysBio (NASDAQ:ANAB) - Defense World
AnaptysBio Inc (ANAB) receives a Buy rating from H.C. Wainwright - Knoxdaily.com
Hedge Fund and Insider Trading News: Carl Icahn, Ken Griffin, Warren Buffett, Engaged Capital, Elliott Management, Oslo Asset Management, AnaptysBio Inc (ANAB), and More - Insider Monkey
Guggenheim maintains buy on AnaptysBio shares, cites ANAB032 potential By Investing.com - Investing.com Canada
Insiders Buying Yum China And 2 Other Stocks - Benzinga
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by California State Teachers Retirement System - Defense World
Short Interest in AnaptysBio, Inc. (NASDAQ:ANAB) Rises By 9.3% - Defense World
Ecor1 Capital, Llc Buys 273,972 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Assenagon Asset Management S.A. Has $7.68 Million Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update - MarketBeat
Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com Australia
Truist Financial Increases AnaptysBio (NASDAQ:ANAB) Price Target to $30.00 - Defense World
AnaptysBio, Inc. to Post Q3 2024 Earnings of ($1.57) Per Share, HC Wainwright Forecasts (NASDAQ:ANAB) - Defense World
AnaptysBio (NASDAQ:ANAB) Stock Price Up 6.6% After Insider Buying Activity - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Major Shareholder Ecor1 Capital, Llc Acquires 273,972 Shares - MarketBeat
Public Equity Report: AnaptysBio, Avidity draw nine-digit offerings - BioCentury
Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com Canada
Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com UK
AnaptysBio (NASDAQ:ANAB) Trading Up 6.6% Following Insider Buying Activity - MarketBeat
Q3 2024 Earnings Forecast for AnaptysBio, Inc. Issued By HC Wainwright (NASDAQ:ANAB) - MarketBeat
Nothing is Better Than AnaptysBio Inc (ANAB) stock at the moment - SETE News
AnaptysBio (NASDAQ:ANAB) Reaches New 12-Month High at $41.11 - Defense World
Metric Analysis: AnaptysBio Inc (ANAB)’s Key Ratios in the Limelight - The Dwinnex
AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% - MarketBeat
AnaptysBio: Top-Line AD Data End Of 2024 Could Be Turning Point (NASDAQ:ANAB) - Seeking Alpha
AnaptysBio shares hold rating; price target raised on pipeline programs By Investing.com - Investing.com Canada
AnaptysBio’s (ANAB) Buy Rating Reaffirmed at HC Wainwright - Defense World
AnaptysBio shares hold rating; price target raised on pipeline programs By Investing.com - Investing.com UK
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $30.00 - MarketBeat
AnaptysBio announces pricing of $100 million offering - The Pharma Letter
ANAB’s Financial Health: Exploring AnaptysBio Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
AnaptysBio (NASDAQ:ANAB) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
AnaptysBio Inc [ANAB] stock was sold by Lizzul Paul F. at the price of US$52500.0 - Knox Daily
AnaptysBio stock soars to 52-week high, hits $38.91 By Investing.com - Investing.com Canada
AnaptysBio (NASDAQ:ANAB) Sets New 12-Month High at $41.11 - MarketBeat
AnaptysBio stock soars to 52-week high, hits $38.91 - Investing.com India
AnaptysBio stock soars to 52-week high, hits $38.91 - Investing.com
AnaptysBio stock soars to 52-week high, hits $38.91 By Investing.com - Investing.com UK
Bicycle Therapeutics (NASDAQ:BCYC) and AnaptysBio (NASDAQ:ANAB) Head-To-Head Analysis - Defense World
Anaptysbio (ANAB) Prices 2.75M Share Offering at $36.50/sh - StreetInsider.com
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering - ForexTV.com
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering - StockTitan
Investors in AnaptysBio (NASDAQ:ANAB) have seen respectable returns of 74% over the past year - Yahoo Finance
Vanguard Group Inc. Has $30.49 Million Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
Vanguard Group Inc. Sells 26,112 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
(ANAB) On The My Stocks Page - Stock Traders Daily
자본화:
|
볼륨(24시간):